Navigating Pediatric Cor Pulmonale: A Comprehensive Review of Diagnosis and Management
- PMID: 39323679
- PMCID: PMC11422785
- DOI: 10.7759/cureus.67782
Navigating Pediatric Cor Pulmonale: A Comprehensive Review of Diagnosis and Management
Abstract
Pediatric cor pulmonale, characterized by right ventricular dysfunction due to chronic pulmonary hypertension, presents significant diagnostic and management challenges. This comprehensive review delves into this complex condition's etiology, clinical presentation, diagnostic strategies, and management. Key etiological factors include congenital heart defects, chronic lung diseases, and pulmonary vascular disorders. Early diagnosis, facilitated by imaging, hemodynamic assessments, and laboratory investigations, is crucial for effective intervention. Pediatric cor pulmonale management encompasses pharmacological treatments, such as vasodilators, diuretics, and inotropic agents, and non-pharmacological interventions, including oxygen therapy, mechanical ventilation, and surgical options. Long-term follow-up is essential to monitor disease progression and adjust treatment strategies accordingly. Multidisciplinary care involving pediatric cardiologists, pulmonologists, and critical care specialists is paramount to address the multifaceted needs of these patients. The review highlights the importance of early recognition and comprehensive care, offering insights into current best practices and future research and clinical practice directions. Advances in understanding the pathophysiology of pediatric cor pulmonale and emerging therapies promise to improve patient outcomes, underscoring the need for continued collaboration and innovation in this field.
Keywords: congenital heart defects; diagnostic strategies; multidisciplinary care; pediatric cor pulmonale; pulmonary hypertension; right ventricular dysfunction.
Copyright © 2024, Thakur et al.
Conflict of interest statement
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
Similar articles
-
The management of cor pulmonale.Heart Dis. 2000 Nov-Dec;2(6):431-7. Heart Dis. 2000. PMID: 11728294 Review.
-
Chronic obstructive pulmonary disease and the early stage of cor pulmonale: A perspective in treatment with pulmonary arterial hypertension-approved drugs.Respir Investig. 2019 Jul;57(4):325-329. doi: 10.1016/j.resinv.2019.03.013. Epub 2019 May 10. Respir Investig. 2019. PMID: 31085118 Review.
-
Cor pulmonale: an overview.Semin Respir Crit Care Med. 2003 Jun;24(3):233-44. doi: 10.1055/s-2003-41105. Semin Respir Crit Care Med. 2003. PMID: 16088545
-
Chronic cor pulmonale. Etiology and management.JAMA. 1990 May 2;263(17):2347-53. JAMA. 1990. PMID: 2182919 Review.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
References
-
- The importance of early intervention in CHF--signs and symptom relief. Schunkert H. J Renin Angiotensin Aldosterone Syst. 2000;1 Suppl 1:17–23. - PubMed
-
- Congenital heart defects. [ May; 2024 ]. https://medlineplus.gov/congenitalheartdefects.html https://medlineplus.gov/congenitalheartdefects.html
Publication types
LinkOut - more resources
Full Text Sources